DRIO - Company ID 0001533998
The table below shows DarioHealth Corp.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$25.94M | -$38.56M | -$30.38M | -$47.84M | -$50.41M | -$17.74M |
| Capital expenditure | $142.00K | $138.00K | $584.00K | $442.00K | $261.00K | $118.00K |
| Investing cash flow | -$4.34M | -$8.93M | -$547.00K | -$573.00K | -$8.13M | -$1.62M |
| Dividends paid | - | - | - |
DarioHealth Corp. reported operating cash flow of -$25.94M for fiscal year 2025. That is up 32.7% from -$38.56M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$8.38M (FY 2016) to -$25.94M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | $134.00K | - | - |
| Financing cash flow | $24.31M | $38.53M | $18.25M | $61.94M | $65.77M | $27.55M |